Physician

Alan Edward Miller, M.D.

According to 2025 Medicare claims, Alan Miller, M.D. (NPI: 1750400792) practices interventional pain management (ipm) in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Nassau, FL. This provider's primary affiliated billing organization is PHYSICIANS GROUP SERVICES PA (NPI: 1861440810; TIN: 593591435) and primary practice location at 32034-4779. Miller is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Miller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,716 traditional Medicare patients, billed 66,872 HCPCS/CPT codes, and received $941,705 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,133 prescription claims across 1,939 beneficiaries totaling $447,731 in drug costs, led by Botox (Onabotulinumtoxina). 2023 DME data shows 15 claims. Open Payments data shows 46 records totaling $7,193. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,855,416 to $941,705. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,252 to $1,128.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,055	58,675	$1,855,416
2016	1,157	19,586	$1,017,052
2017	1,237	19,874	$1,115,859
2018	1,254	21,494	$1,006,067
2019	1,433	20,224	$977,799
2020	1,189	17,848	$840,751
2021	1,232	17,655	$957,955
2022	1,291	18,445	$896,088
2023	1,640	20,676	$1,009,867
2024	1,716	66,872	$941,705

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	815	5,431	$397,647
2016	853	5,386	$372,992
2017	1,014	6,491	$388,254
2018	969	5,514	$334,585
2019	1,150	6,902	$415,399
2020	997	5,953	$335,305
2021	1,179	6,556	$375,217
2022	1,150	5,341	$315,331
2023	1,737	6,896	$392,795
2024	1,939	9,133	$447,731

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	64	75	$48,139
2016	21	21	$21,374
2017	N/R	N/R	N/R
2018	11	31	$12,781
2019	N/R	28	$1,636
2020	N/R	38	$2,529
2021	N/R	25	$1,275
2022	N/R	N/R	N/R
2023	N/R	15	$1,059
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,177	2,877	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	688	1,115	$63
80307	Testing for presence of drug, by chemistry analyzers	414	491	$61
J1010	Injection, methylprednisolone acetate, 1 mg	456	43,427	$0
J1100	Injection, dexamethasone sodium phosphate, 1 mg	281	4,271	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Botox	Onabotulinumtoxina	50	4,476	$59,658
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	1,374	38,091	$50,723
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,531	41,707	$41,815
Lidocaine	Lidocaine	179	5,769	$22,120
Qulipta	Atogepant	14	480	$18,753

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$1,412	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$5,781	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan Edward Miller, M.D.?

Tedicare shows public-source Medicare data for Alan Edward Miller, M.D. (NPI 1750400792), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Edward Miller, M.D. have ACO affiliation data?

Alan Edward Miller, M.D. is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Alan Edward Miller, M.D.?

Alan Edward Miller, M.D. is linked to PHYSICIANS GROUP SERVICES PA (billing NPI 1861440810) in the available physician profile data.

Does Alan Edward Miller, M.D. have Open Payments data?

Alan Edward Miller, M.D. has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.